CEBPA and acute myeloid leukemia: Numerous systemic investigations involving a series of genes have been performed in AML using first or second generation of sequencing techniques, and prognostic value has been analyzed, especially for the most common ones, such as NPM1, CEBPA, FLT3 etc. [11, 13, 47].